These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5142661)

  • 1. Statistical characteristics of the USP content uniformity test.
    Pedersen AO; Torud Y
    Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: USP content uniformity test.
    Madan PL
    J Pharm Sci; 1976 Jan; 65(1):VIII. PubMed ID: 1255410
    [No Abstract]   [Full Text] [Related]  

  • 3. The USP content uniformity test. Analysis and proposals.
    Setnikar I
    Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: USP content uniformity test.
    Banes D
    J Pharm Sci; 1976 Apr; 65(4):IV. PubMed ID: 1271243
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
    Schepers U; Wätzig H
    J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations.
    Senderak ET
    Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical analysis of the USP 18 content uniformity sampling plan for tablets.
    Langenbucher F
    Pharm Acta Helv; 1972; 47(2):142-52. PubMed ID: 5024143
    [No Abstract]   [Full Text] [Related]  

  • 9. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-stage sequential statistical dissolution testing rules.
    Tsong Y; Shen M; Shah VP
    J Biopharm Stat; 2004 Aug; 14(3):757-79. PubMed ID: 15468763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 12. USP standards.
    Banes D
    Am J Hosp Pharm; 1976 Dec; 33(12):1245. PubMed ID: 998641
    [No Abstract]   [Full Text] [Related]  

  • 13. An epic decision by USP.
    Provost GP
    J Am Pharm Assoc; 1977 Sep; 17(9):547. PubMed ID: 893923
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of USP-NF to NDA and ANDA "Standards".
    Belson JJ
    Am J Hosp Pharm; 1982 May; 39(5):869-70. PubMed ID: 7081269
    [No Abstract]   [Full Text] [Related]  

  • 15. USP and the Drug Regulation Reform Act.
    Heller WM
    J Parenter Drug Assoc; 1979; 33(2):55-60. PubMed ID: 255147
    [No Abstract]   [Full Text] [Related]  

  • 16. Parametric two-stage sequential quality assurance test of dose content uniformity.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(1):143-57. PubMed ID: 17219760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP standards for dissolution and bioavailability.
    Grady LT
    Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198
    [No Abstract]   [Full Text] [Related]  

  • 18. Voluntary standards--the USP and the PDA.
    Schmitz AJ
    J Parenter Drug Assoc; 1980; 34(6):425-6. PubMed ID: 6906364
    [No Abstract]   [Full Text] [Related]  

  • 19. General requirements for parenteral pharmaceuticals for the 21st USP revision--for the 21st Century.
    Barnstein CH
    J Parenter Drug Assoc; 1979; 33(5):287-9. PubMed ID: 259651
    [No Abstract]   [Full Text] [Related]  

  • 20. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.